# Gilles Alberici

> Gilles Alberici is a seed investor at Octalfa (Écully) backing Medical and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Octalfa](https://shizune.co/investors/profile/octalfa)
- Location: Écully, France
- Total investments: 1
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/gilles-alberici-7868ba111/

Gilles Alberici is a pharmacist and doctor of immunology. From 1994 to 1999 he founded and directed Imtix-in Pasteur-Mérieux-then-Imtix SangStat. More recently (1999 to 2007), he developed OPi, Pharmaceuticals for Rare diseases.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biotechnology | 1 | 100% |
| Consumer Research | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ventuno Biotech | Ventuno Biotech is a biotech company that is developing innovative cancer therapies. | $2.3M | Seed |  |  |

1 of 1 investments shown.

## Co-investors
- [Octalfa](https://shizune.co/investors/profile/octalfa) — VC Fund, 1 deal together
- [Relyens](https://shizune.co/investors/profile/relyens) — VC Fund, 1 deal together

## About Octalfa

VC Fund · Écully, France

Octalfa is a France-based venture capital firm that offers a range of financial services.

5 contacts available at Octalfa.

| Name | Title | Profile |
| --- | --- | --- |
| Annie Beucler | Administrative Manager | https://shizune.co/investors/profile/annie-beucler |
| Gilles Alberici | President | https://shizune.co/investors/profile/gilles-alberici |
| Jérémy Bastid | R&D Director | https://shizune.co/investors/profile/jrmy-bastid |
| Julien Alberici | Operations Manager | https://shizune.co/investors/profile/julien-alberici |
| Laurence Simon | Administrative and Financial Director | https://shizune.co/investors/profile/laurence-simon |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Medical Angel Investors in France](https://shizune.co/investors/medical-angel-investors-france)

## FAQ

### What does Gilles Alberici invest in?

Gilles Alberici invests primarily in Medical, Biotechnology and Consumer Research startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co